NALPROPION PHARMACEUTICALS
Nalpropion Pharmaceuticals is a patient-focused company dedicated to help improve the health of patients struggling to lose weight.The company focuses on the treatment of weight loss with the use of a medication called Contrave.
NALPROPION PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2018-04-17
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.nalpropion.com
Total Employee:
51+
Status:
Active
Contact:
(858) 875-8600
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS GoDaddy DNS AWS Global Accelerator JotForm
Similar Organizations
Ciclofilin Pharmaceuticals
Ciclofilin Pharmaceuticals is a biopharmaceutical company specializing in development of cyclophilin inhibitors.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Satiogen Pharmaceuticals
Satiogen Pharmaceuticals is a specialty pharma company focused on novel-target for treating type 2 diabetes.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-04-24 | Orexigen Therapeutics | Orexigen Therapeutics acquired by Nalpropion Pharmaceuticals | 75 M USD |
Official Site Inspections
http://www.nalpropion.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Nalpropion Pharmaceuticals"
Nalpropion Pharmaceuticals - Crunchbase Company Profile
Nalpropion Pharmaceuticals is a biopharmaceutical company focused on the treatment of weight loss. View contacts for Nalpropion Pharmaceuticals to access new leads and connect with …See details»
Currax™ Pharmaceuticals LLC Announces the Acquisition of …
Sep 27, 2019 · Morristown, NJ – Currax Pharmaceuticals LLC, a specialty biopharmaceutical company with both Branded and generic business units, announced today the acquisition of …See details»
Currax Pharmaceuticals Delivers Strong Operational and Financial ...
Feb 27, 2020 · Successfully Completed Two Acquisitions – Nalpropion Pharmaceuticals, Inc. and ONZETRA® Xsail® Anticipate 2020 revenues in excess of $100M, driven by growth in …See details»
Currax™ Pharmaceuticals LLC Announces the Acquisition of …
MORRISTOWN, N.J., Sept. 27, 2019 /PRNewswire/ -- Currax Pharmaceuticals LLC, a specialty biopharmaceutical company with both Branded and generic business units, announced today …See details»
Nalpropion Pharmaceuticals acquired by Currax Pharmaceuticals
Acquiring Organization: Currax Pharmaceuticals Currax Pharmaceuticals is a specialty pharmaceutical business focused on acquiring and commercializing prescription drugs. …See details»
Nalpropion Pharmaceuticals - PitchBook
Information on acquisition, funding, investors, and executives for Nalpropion Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Nalpropion Pharmaceuticals - Contacts, Employees, Board …
Nalpropion Pharmaceuticals has 1 current employee profile, CEO George Hampton. Nalpropion Pharmaceuticals is a biopharmaceutical company focused on the treatment of weight loss.See details»
Nalpropion Pharmaceuticals - VentureRadar
Nalpropion is a biopharmaceutical company focused on the treatment of weight loss. The company is undertaking a range of commercialization activities, both on their own and with key …See details»
Currax Pharmaceuticals Delivers Strong Operational and Financial ...
Feb 27, 2020 · In connection with the Nalpropion acquisition, Currax has shifted its sales model, transitioning to a nimble, 57-person in-house sales team, which has already accelerated …See details»
Currax Pharmaceuticals Announces the Acquisition of Nalpropion ...
Sep 30, 2019 · Currax Pharmaceuticals LLC, a specialty biopharmaceutical company with both Branded and generic business units, announced the acquisition of Nalpropion …See details»
Currax™ Acquires Nalpropion Pharmaceuticals | American …
Sep 27, 2019 · Currax Pharmaceuticals announced the acquisition of Nalpropion Pharmaceuticals. As a result of this acquisition, Currax now owns the world-wide rights to …See details»
Orexigen Enters into Agreement to Sell Company to Newly
One month after filing for bankruptcy anti-obesity company Orexigen Therapeutics, Inc. could be acquired by the newly-formed company Nalpropion Pharmaceuticals, Inc. for $75 million in cash.See details»
Nalpropion Pharmaceuticals, Inc. Expands Agreement with
Dec 19, 2018 · Nalpropion Pharmaceuticals, Inc. is a privately held biopharmaceutical company focused on the treatment of obesity. Its product, Contrave ® (naltrexone HCl and bupropion …See details»
Nalpropion Pharmaceuticals - Funding, Financials, Valuation
Apr 24, 2018 · Nalpropion Pharmaceuticals is a biopharmaceutical company focused on the treatment of weight loss.See details»
Nalpropion Pharmaceuticals LLC - 09/22/2020 | FDA
Below are the indication and summary of the most serious and most common risks associated with the use of Contrave. 2 According to the FDA-approved product labeling (PI) (emphasis …See details»
Update on drug safety evaluation of naltrexone/bupropion for the ...
In 2014, the FDA approved naltrexone/bupropion ER, which is a novel formulation of two generic medications under US patent exclusivity through 2030 and is sold as Contrave® by Nalpropion …See details»
Currax™ Pharmaceuticals LLC Announces the Acquisition of …
Sep 27, 2019 · Currax Pharmaceuticals LLC, a specialty biopharmaceutical company with both Branded and generic business units, announced the acquisition of Nalpropion Pharmaceuticals.See details»
Naltrexone-bupropion for weight loss | The College of Family …
Sep 1, 2023 · Is combination naltrexone-bupropion effective for weight loss? Over 28 to 56 weeks about 50% of patients (at best) taking naltrexone-bupropion achieved a 5% or greater loss in …See details»
What patent practitioners can learn from Nalpropion …
Sep 11, 2021 · For clients in the United States and around the globe, he effectively prepares and files patent applications, develops and implements worldwide patent protection strategies, and …See details»
Update on drug safety evaluation of naltrexone/bupropion for the ...
May 17, 2019 · In 2014, the FDA approved naltrexone/bupropion ER, which is a novel formulation of two generic medications under US patent exclusivity through 2030 and is sold as …See details»